332 related articles for article (PubMed ID: 30425720)
1. Adenosinergic Signaling Alters Natural Killer Cell Functional Responses.
Chambers AM; Wang J; Lupo KB; Yu H; Atallah Lanman NM; Matosevic S
Front Immunol; 2018; 9():2533. PubMed ID: 30425720
[TBL] [Abstract][Full Text] [Related]
2. Purinergic targeting enhances immunotherapy of CD73
Wang J; Lupo KB; Chambers AM; Matosevic S
J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
[TBL] [Abstract][Full Text] [Related]
3. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
4. In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells.
Mukherjee S; Jensen H; Stewart W; Stewart D; Ray WC; Chen SY; Nolan GP; Lanier LL; Das J
Sci Signal; 2017 Jun; 10(485):. PubMed ID: 28655861
[TBL] [Abstract][Full Text] [Related]
5. Cutting Edge: IL-2-Induced Expression of the Amino Acid Transporters SLC1A5 and CD98 Is a Prerequisite for NKG2D-Mediated Activation of Human NK Cells.
Jensen H; Potempa M; Gotthardt D; Lanier LL
J Immunol; 2017 Sep; 199(6):1967-1972. PubMed ID: 28784848
[TBL] [Abstract][Full Text] [Related]
6. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
Front Immunol; 2018; 9():3169. PubMed ID: 30761160
[No Abstract] [Full Text] [Related]
7. Adenosinergic signaling as a target for natural killer cell immunotherapy.
Wang J; Matosevic S
J Mol Med (Berl); 2018 Sep; 96(9):903-913. PubMed ID: 30069747
[TBL] [Abstract][Full Text] [Related]
8. Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
Sabry M; Zubiak A; Hood SP; Simmonds P; Arellano-Ballestero H; Cournoyer E; Mashar M; Pockley AG; Lowdell MW
PLoS One; 2019; 14(6):e0218674. PubMed ID: 31242243
[TBL] [Abstract][Full Text] [Related]
9. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.
Mao Y; van Hoef V; Zhang X; Wennerberg E; Lorent J; Witt K; Masvidal L; Liang S; Murray S; Larsson O; Kiessling R; Lundqvist A
Blood; 2016 Sep; 128(11):1475-89. PubMed ID: 27465917
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.
Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM
Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077
[TBL] [Abstract][Full Text] [Related]
11. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
12. Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15.
Xiong Y; Mouginot M; Reppel L; Qian C; Stoltz JF; Bensoussan D; Decot V
Immunol Res; 2017 Dec; 65(6):1130-1138. PubMed ID: 29019081
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
[TBL] [Abstract][Full Text] [Related]
14. CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.
Wagner JA; Rosario M; Romee R; Berrien-Elliott MM; Schneider SE; Leong JW; Sullivan RP; Jewell BA; Becker-Hapak M; Schappe T; Abdel-Latif S; Ireland AR; Jaishankar D; King JA; Vij R; Clement D; Goodridge J; Malmberg KJ; Wong HC; Fehniger TA
J Clin Invest; 2017 Nov; 127(11):4042-4058. PubMed ID: 28972539
[TBL] [Abstract][Full Text] [Related]
15. The aryl hydrocarbon receptor modulates the function of human CD56
Moreno-Nieves UY; Mundy DC; Shin JH; Tam K; Sunwoo JB
Eur J Immunol; 2018 May; 48(5):771-776. PubMed ID: 29336030
[TBL] [Abstract][Full Text] [Related]
16. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.
Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C
Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474
[TBL] [Abstract][Full Text] [Related]
17. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Huth TK; Staines D; Marshall-Gradisnik S
J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
[TBL] [Abstract][Full Text] [Related]
18. Implication of Highly Cytotoxic Natural Killer Cells for Esophageal Squamous Cell Carcinoma Treatment.
Lim KS; Mimura K; Kua LF; Shiraishi K; Kono K
J Immunother; 2018; 41(6):261-273. PubMed ID: 29683892
[TBL] [Abstract][Full Text] [Related]
19. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
[TBL] [Abstract][Full Text] [Related]
20. BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors.
Felgueres MJ; Esteso G; García-Jiménez ÁF; Dopazo A; Aguiló N; Mestre-Durán C; Martínez-Piñeiro L; Pérez-Martínez A; Reyburn HT; Valés-Gómez M
Sci Rep; 2024 Jun; 14(1):13133. PubMed ID: 38849432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
